Detalles de la búsqueda
1.
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 16(5): 531-40, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25864104
2.
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(7): 700-12, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24831977
3.
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415).
Eur J Cancer
; 158: 63-71, 2021 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34655838
4.
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors.
Eur Urol
; 78(6): 822-830, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32811715
5.
Evaluation of quality of life in patients with metastatic colorectal cancer treated with capecitabine.
Clin Colorectal Cancer
; 7(2): 126-33, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18501072
6.
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.
J Clin Oncol
; 35(1): 40-47, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28034081
7.
Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.
J Clin Oncol
; 31(23): 2849-53, 2013 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23775961
Resultados
1 -
7
de 7
1
Próxima >
>>